N. Ullmann (Roma (RM), Italy), A. Soti (Bern, Switzerland), E. Gaillard (Leicester (Leicestershire), United Kingdom), K. Pike (London, United Kingdom)
Risk factors for PICU admission in children with severe acute asthma: a multicenter prospective study
S. Boeschoten (Rotterdam, Netherlands), A. Boehmer (Rotterdam, Netherlands), P. Merkus (Nijmegen, Netherlands), J. Van Rosmalen (Rotterdam, Netherlands), C. Buysse (Rotterdam, Netherlands), M. De Hoog (Rotterdam, Netherlands)
|   |
Childhood Severe Asthma: Relationship among asthma control scores, FeNO, spirometry and impulse oscilometry.
G. Peláez (Buenos Aires, Argentina), V. Giubergia (Buenos Aires, Argentina), B. Lucero (Buenos Aires, Argentina), V. Aguerre (Buenos Aires, Argentina), J. Figueroa (Buenos Aires, Argentina), C. Claudio (Buenos Aires, Argentina)
| |
PICU admission in children with severe acute asthma: a multicenter prospective study
S. Boeschoten (Rotterdam, Netherlands), C. Buysse (Rotterdam, Netherlands), P. Merkus (Nijmegen, Netherlands), J. Van Rosmalen (Rotterdam, Netherlands), A. Boehmer (Rotterdam, Netherlands), M. De Hoog (Rotterdam, Netherlands)
| |
Defining Near Fatal asthma – an international eDelphi study.
A. Mcmurray (Edinburgh, United Kingdom), S. Cunningham (Edinburgh, United Kingdom), L. Fleming (London, United Kingdom)
| |
Mepolizumab eligibility in children with severe asthma – do we need paediatric specific criteria?
B. Davies (Birmingham, United Kingdom), D. Chinthala (Birmingham, United Kingdom), S. Frost (Birmingham, United Kingdom), I. Brookes (Birmingham, United Kingdom), P. Kenia (Birmingham, United Kingdom), S. Rao (Birmingham, United Kingdom), P. Nagakumar (Birmingham, United Kingdom)
| |
An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations
C. Rodriguez Martinez (Bogota, Colombia), M. Sossa-Briceño (Bogota, Colombia), J. Castro-Rodriguez (Chile, Colombia)
| |
Dexamethasone or prednisolone for acute asthma exacerbations in children: a meta-analysis
D. Nitchingham (Liverpool, United Kingdom), D. Hawcutt (Liverpool, United Kingdom), R. Fernandes (Lisbon, Portugal), B. Kapitein (Amsterdam, Netherlands), L. Andrew (Liverpool, United Kingdom), J. Grice (Liverpool, United Kingdom), H. Cibinda (Liverpool, United Kingdom), M. O'Connor (Liverpool, United Kingdom), I. Sinha (Liverpool, United Kingdom)
| |
Is fungal sensitisation associated with exacerbation-prone or severe preschool wheezing?
K. Holden (Leicester, United Kingdom), D. Lo (Leicester, United Kingdom), E. Gaillard (Leicester, United Kingdom)
| |
Clinical characteristics, lung function, quality of life, exercise capacity and inflammatory biomarkers in induced sputum and serum in children and adolescents with uncontrolled severe asthma.
N. Matsunaga (Campinas , Brazil), T. Mazzola (Campinas , Brazil), M. Oliveira (Campinas , Brazil), L. Gianfrancesco (Campinas , Brazil), B. Zaidan (Campinas , Brazil), I. Barreto (Campinas , Brazil), A. Morcillo (Campinas , Brazil), M. Toro (Campinas , Brazil), M. Simões (Campinas , Brazil), M. Ribeiro (Campinas , Brazil), J. Ribeiro (Campinas , Brazil), A. Dalbo Contrera Toro (Campinas , Brazil)
| |
Anti-IgE treatment in children with severe intrinsic asthma
G. Fenu (Florence, Italy), E. Lombardi (Florence, Italy)
| |
Characterization of severe asthma in the pediatric population of Tarragona. Observational study.
A. Bobe (Tarragona, Spain), A. Vasquez (Tarragona, Spain), E. Rua (Tarragona, Spain), M. Garcia (Tarragona, Spain), A. Gomez (Tarragona, Spain), M. Pascual (Tarragona, Spain), M. Bosque-Garcia (Sabadell, Spain)
| |
Infants with severe preschool wheeze: results of a 3 year survey of 138 patients
H. PETAT (ROUEN, France), C. Marguet (ROUEN, France), J. Raghani (ROUEN, France), A. Chabbat (ROUEN, France)
| |
Respiratory rate monitoring from pulse oximetry to assess treatment response in acute preschool wheeze
O. Anton (Brighton, United Kingdom), D. Wertheim (Kingston, United Kingdom), C. Olden (Brighton, United Kingdom), P. Seddon (Brighton, United Kingdom)
| |
Asthma medication from 2 to 13 years in a Swedish birth cohort
E. Goksör (Gothenburg, Sweden), F. Strömberg Celind (Gothenburg, Sweden), S. Vasileiadou (Gothenburg, Sweden), P. Möllborg (Gothenburg, Sweden), N. Åberg (Gothenburg, Sweden), R. Pettersson (Gothenburg, Sweden), B. Alm (Gothenburg, Sweden), G. Wennergren (Gothenburg, Sweden)
| |
Adverse events and cardiovasular effects of vilanterol in paediatric asthma: a systematic review
R. Austin (Liverpool, United Kingdom), I. Sinha (Liverpool, United Kingdom), D. Hawcutt (Liverpool, United Kingdom)
| |
Antistatic treatment and the amount of salbutamol actuated have variable effect on drug delivery of six different valved holding chambers (VHC)
P. Csonka (Tampere, Finland), L. Lehtimäki (Tampere, Finland)
| |
Use of mouthpiece with the VR647 inhalation system in children aged 1 to 4 years
L. Bacharier (St. Louis, MO, United States of America), G. Burgess (Chippenham, United Kingdom), B. Müllinger (Gauting, Germany), S. Snape (Chippenham, United Kingdom)
| |
Clinically Appropriate Testing of Valved Holding Chambers with Facemask - Impact of Substitution
M. Nagel (London, Canada), J. Suggett (London, Canada), V. Avvakoumova (London, Canada), A. Bracey (Hampshire, United Kingdom)
| |
Forced oscillation technique (FOT) and Impulse Oscillometry (IOS) depict longer duration of disease in children with Sickle cell disease (SCD) while N2-Multiple-breath-washout (N2MBW) provides new insight on respiratory pattern
F. Lucca (Verona, Italy), M. Piazza (Verona, Italy), L. Tenero (Verona, Italy), E. Bonetti (Verona, Italy), S. Cesaro (Verona, Italy), G. Piacentini (Verona, Italy)
| |
The march from subclinical small-airways dysfunction to asthma in children with allergic rhinitis
E. Skylogianni (Patras, Greece), M. Triga (Patras, Greece), K. Bolis (Patras, Greece), M. Anthracopoulos (Patras, Greece), S. Fouzas (Patras, Greece)
| |